HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 539Generated: October 24, 2026
Benzylamine → 4-N-benzyl-2-N-phenylpyridine-2,4-diamine
https://huagongshe.com/en/reaction/539
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Benzylamine | HCID 7504 | — |
| Reactant | 4-chloro-N-phenylpyridin-2-amine | HCID 23458041 | — |
| Reagent | Sodium t-butoxide | HCID 23676156 | — |
| Catalyst | Palladium (II) acetate | HCID 4144353 | — |
| Catalyst | (R)-(-)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine;Ferrocene, 1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)-, (2R)- | HCID 144543273 | — |
| Solvent | Dimethylacetamide | HCID 31374 | — |
| Product | 4-N-benzyl-2-N-phenylpyridine-2,4-diamine | HCID 101883688 | 53.81% |
Reaction Steps
Phenylmethanamine (57.6 mg, 0.54 mmol), 4-chloro-N-phenylpyridin-2-amine (100 mg, 0.49 mmol) and sodium 2-methylpropan-2-olate (94 mg, 0.98 mmol) were suspended in DMA (2 mL) and sealed into a microwave tube. Nitrogen was bubbled through the reaction mixture for 5 minutes. (R)-(-)-1-[(S)-2-(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDI-T-BUTYLPHOSPHINE (32.5 mg, 0.06 mmol) and diacetoxypalladium (8.78 mg, 0.04 mmol) were added to the reaction mixture and nitrogen was bubbled through the reaction mixture for a further 5 minutes. The reaction was heated thermally to 100 °C for 30 mins under nitrogen and cooled to RT. The reaction mixture was neutralised with HCl and purified by ion exchange chromatography, using a 20 g SCX column. The crude product was purified by preparative HPLC (Waters SunFire column, 5µ silica, 50 mm diameter, 100 mm length), using decreasingly polar mixtures of water (containing 0.1% formic acid) and MeCN as eluents. Fractions containing product were evaporated to dryness to afford N4-benzyl-N2-phenylpyridine-2,4-diamine (72.4 mg, 53.8 %) as an off-white solid.
Provenance & Evidence
| Source dataset | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-ca21e23d9a8e4bdaa490a5abf62f7063 |
|---|
| Source note | 750 AstraZeneca ELN dataset |
|---|